T Cell-Specific BRCA1 Function in Antitumor Immunity and Immunotherapy
T 细胞特异性 BRCA1 在抗肿瘤免疫和免疫治疗中的功能
基本信息
- 批准号:10716957
- 负责人:
- 金额:$ 61.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-15 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAgeAttenuatedBRCA1 MutationBRCA1 geneBreast Epithelial CellsCD8-Positive T-LymphocytesCancer BiologyCancer EtiologyCellsCellular biologyClinicalComplementCoupledDNA Double Strand BreakDNA RepairDataDefectDevelopmentDimensionsDouble Strand Break RepairEpitheliumFoundationsGeneticGenomic InstabilityGerm-Line MutationHeterozygoteHumanImmuneImmune EvasionImmune systemImmunotherapyImpairmentIncidenceKnock-outKnowledgeLabelLaboratory FindingMalignant NeoplasmsMass Spectrum AnalysisMature T-LymphocyteMolecularMusNeoplasmsOncogenesOperative Surgical ProceduresPositioning AttributeResearchRiskRisk ReductionRoleSamplingSomatic CellT-LymphocyteTechnologyTestingTimeTranscriptional RegulationTumor ImmunityTumor Suppressor ProteinsWomanWorkbreast tumorigenesiscancer immunotherapycancer preventioncancer riskcohortdriving forceepithelial repairexperimental studygenomic toolslifetime riskmalignant breast neoplasmmammary epitheliummouse geneticsmultidisciplinarymutantmutant mouse modelmutation carriermutational statusneoplasm immunotherapyneoplastic cellnovelpreclinical studyprophylacticrepairedresponsetooltranslational impacttumortumor immunologytumorigenesisvirtual
项目摘要
ABSTRACT
Women with germline mutations of BRCA1 have about an 80% lifetime risk of developing breast cancer. All
somatic cells in a germline BRCA1 mutation carrier harbor the same mutant copy of the BRCA1 gene, yet BRCA1
research is almost exclusively focused on BRCA1’s role in repair of double-strand DNA breaks in the breast
epithelium. This is due to the cardinal tenet of the current BRCA1 paradigm — increased genetic instability of
the breast epithelium solely drives development of BRCA1 mutation-related breast cancer. In addition, current
prophylactic risk-reducing surgeries are aimed at curtailing tumorigenesis of breast epithelial cells of BRCA1
mutation carriers. In contrast, virtually nothing is known about whether BRCA1 heterozygosity in cells beyond
the breast epithelium could also contribute to BRCA1-related tumorigenesis.
Neoplasia is antagonized by the ability of the immune system to detect and eliminate neoplastic cells. Clearly,
impaired antitumor immunity enables immune evasion and tumor outgrowth. We recently found that women with
BRCA1 germline mutations have less abundant circulating CD8+ T cells versus age-matched donors with wild-
type BRCA1 genes. In support of this clinical finding, heterozygous knockout of Brca1 specifically in CD8+ T cells
of mice is sufficient to attenuate antitumor immunity. Based on our preliminary data, we hypothesize that T cell-
intrinsic function of BRCA1 in enhancing antitumor immunity contributes to the overall tumor
suppressor activity of BRCA1. We further propose that in BRCA1 mutation carriers, increased genomic
instability in the breast epithelium and attenuated antitumor immunity in CD8+ T cells act together to elevate
cancer incidence. To validate this novel hypothesis, we will combine our established team’s tools and expertise
in cancer biology, tumor immunology, and transcriptional regulation through the following three Specific Aims:
(1) Discern the impact of T cell-intrinsic BRCA1 on antitumor immunity and immunotherapy, (2) Elucidate the
molecular basis for BRCA1’s function in antitumor immunity, and (3) Examine BRCA1 mutation-related T cell
deficiency in human samples.
Our proposed work represents a new direction in elucidating a previously unappreciated tumor-suppressing
function of BRCA1 in immune cells. The concept to be validated clearly departs from the prevailing paradigm
regarding BRCA1-related cancer etiology, which is focused on the breast epithelium and DNA repair. From a
translational perspective, our proposed study focusing on BRCA1 in immune cells will likely inform development
of novel immune-boosting strategies for women with BRCA1 germline mutations. Thus, this line of work has
potential for far-reaching and sustained impact on breast cancer cancer risk reduction.
摘要
具有BRCA 1生殖系突变的女性患乳腺癌的风险约为80%。所有
生殖系BRCA 1突变携带者中的体细胞具有相同的BRCA 1基因突变拷贝,但BRCA 1
研究几乎完全集中在BRCA 1在修复乳房双链DNA断裂中的作用上
上皮这是由于当前BRCA 1范式的主要原则-增加的遗传不稳定性,
乳腺上皮仅驱动BRCA 1突变相关乳腺癌的发展。此外,目前
预防性降低风险的手术旨在减少BRCA 1乳腺上皮细胞的肿瘤发生
变异携带者相比之下,几乎没有人知道BRCA 1杂合性在细胞中是否超过
乳腺上皮也可能参与BRCA 1相关的肿瘤发生。
免疫系统检测和消除肿瘤细胞的能力可对抗肿瘤形成。很显然,
受损的抗肿瘤免疫使免疫逃避和肿瘤生长成为可能。我们最近发现,
BRCA 1生殖系突变与年龄匹配的野生型供体相比,循环CD 8 + T细胞的丰度较低。
型BRCA 1基因。为了支持这一临床发现,在CD 8 + T细胞中特异性地杂合敲除Brca 1,
足以减弱抗肿瘤免疫力。根据我们的初步数据,我们假设T细胞-
BRCA 1在增强抗肿瘤免疫中的内在功能有助于整体肿瘤
BRCA 1的抑制活性。我们进一步提出,在BRCA 1突变携带者中,
乳腺上皮细胞的不稳定性和CD 8 + T细胞中减弱的抗肿瘤免疫力共同作用,
癌症发病率为了验证这一新的假设,我们将联合收割机结合我们现有团队的工具和专业知识
在癌症生物学,肿瘤免疫学和转录调控通过以下三个具体目标:
(1)探讨T细胞内源性BRCA 1对抗肿瘤免疫和免疫治疗的影响。
BRCA 1在抗肿瘤免疫中作用的分子基础;(3)检测BRCA 1突变相关的T细胞
人体样本的缺陷。
我们提出的工作代表了一个新的方向,阐明了以前不受重视的肿瘤抑制,
BRCA 1在免疫细胞中的作用有待验证的概念显然背离了普遍的模式
关于BRCA 1相关的癌症病因学,重点是乳腺上皮和DNA修复。从
从翻译的角度来看,我们提出的研究重点是免疫细胞中的BRCA 1,这可能会为发展提供信息。
为BRCA 1生殖系突变的女性提供新的免疫增强策略。因此,这一行的工作,
对降低乳腺癌风险具有深远和持续影响的潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YANFEN HU其他文献
YANFEN HU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YANFEN HU', 18)}}的其他基金
A Dual Functional Switch in Reproductive Biology
生殖生物学中的双功能开关
- 批准号:
9386993 - 财政年份:2017
- 资助金额:
$ 61.46万 - 项目类别:
Role of BRCA1 phosphorylation in DNA DSB repair and genome stability maintenance
BRCA1 磷酸化在 DNA DSB 修复和基因组稳定性维持中的作用
- 批准号:
9753187 - 财政年份:2017
- 资助金额:
$ 61.46万 - 项目类别:
Role of BRCA1 phosphorylation in DNA DSB repair and genome stability maintenance
BRCA1 磷酸化在 DNA DSB 修复和基因组稳定性维持中的作用
- 批准号:
10251866 - 财政年份:2017
- 资助金额:
$ 61.46万 - 项目类别:
Role of BRCA1 phosphorylation in DNA DSB repair and genome stability maintenance
BRCA1 磷酸化在 DNA DSB 修复和基因组稳定性维持中的作用
- 批准号:
9381864 - 财政年份:2017
- 资助金额:
$ 61.46万 - 项目类别:
(PQA-2) Reprogramming of circulating adipose stromal cells by mechanical stress
(PQA-2) 通过机械应力对循环脂肪基质细胞进行重编程
- 批准号:
8677425 - 财政年份:2014
- 资助金额:
$ 61.46万 - 项目类别:
FBX044 mediated BRCA1 degradation in sporadic breast cancers
FBX044 介导散发性乳腺癌中 BRCA1 降解
- 批准号:
8623171 - 财政年份:2014
- 资助金额:
$ 61.46万 - 项目类别:
FBX044 mediated BRCA1 degradation in sporadic breast cancers
FBX044 介导散发性乳腺癌中 BRCA1 降解
- 批准号:
8787951 - 财政年份:2014
- 资助金额:
$ 61.46万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 61.46万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 61.46万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 61.46万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 61.46万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 61.46万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 61.46万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 61.46万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 61.46万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 61.46万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 61.46万 - 项目类别:
Directed Grant